Cannabidiol: consumer products

spotlight topic:

Consumer products

Published 23 April 2023 | Updated 16 May 2023

Consumer products should not make claims relating to efficacy and are not formally authorised for sale or assessed for safety. However, some monitoring has been carried out to check whether the CBD levels meet the declared value; the levels of contaminants, such as heavy metals and pesticides, and whether the level of THC+ (the total sum of illicit cannabinoids in the product) exceeds the 50 micrograms (µg) per unit of consumption threshold outlined in current  guidance.


Advisory Council on the Misure of Drugs (2021) Consumer Cannabidiol (CBD) products. Available from: [Accessed 23 April 2023]

Online full-text available to Library members

A range of library membership packages is available and MRCVS vets and RVNs can join the library for a heavily subsidised, annual fee.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *


This site uses Akismet to reduce spam. Learn how your comment data is processed.